News Focus
News Focus
icon url

AdamS007

08/06/20 5:16 PM

#19851 RE: Kk9 #19850

Hi KK, yes I absolutely do, Testing, especially antibody is going to be needed for years to come. They have a low float, so a drop in the bucket for $3-5 a share for any Fund, Pharma etc to pay for them...

We know for a fact that the 43% margins make their testing VERY profitable so either way is good, but a buyout is quicker....

GLTU!

$ABMC
icon url

One11

08/06/20 5:19 PM

#19852 RE: Kk9 #19850

There's always a chance.
icon url

skankhuntfortytwo

08/06/20 5:34 PM

#19858 RE: Kk9 #19850

I dont think it makes sense for a company financially to acquire a dying company like ABMC. CV19 is why they havnt died completely during the pandemic, but they are ONLY distributing a test. If ABMC had developed their own test, then I think there was a possibility. But as it stands, I'll bet my ABMC shares it doesnt happen.